Investor Brief · May 2026
Confidential
Europe's first longevity
wellness advisory platform
Blood-work led. Personalised protocols. Vetted practitioners.
EU-wide. Already live.
Seed Round
€2M
SAFE / Equity · Open
$7.68B
EU health coaching market by 2029 · 6.9% CAGR
$247B
Global longevity & alt. medicine by 2030 · 21.5% CAGR
32%
Europe's share of global longevity market · largest region
450M+
EU adults · 20% over 65 today, rising to 30% by 2050
The Problem
Longevity is booming.
Personalised access is broken.
  • Too expensive & fragmented — Personalised longevity guidance costs £2,000–10,000/yr at private clinics. Most people can't access it.
  • No EU-wide platform exists — No marketplace connects vetted longevity advisors, blood testing, and protocols at scale across Europe.
  • Peptides & bioactives go unguided — Millions self-experimenting with no clinical oversight or personalisation based on their own biomarkers.
  • Social media ≠ personalised advice — Content is abundant. Blood-work-led 1-to-1 guidance from vetted practitioners is not.
The Solution
HealthHub: the longevity advisory
platform for Europe
  • Marketplace of vetted advisors — longevity, hormonal wellness, nutrition, performance coaches. CPD-certified practitioners, not doctors.
  • Blood-work led protocols — every client gets a blood panel, lab referral, and personalised protocol built from their actual biomarkers.
  • EU physician oversight — EU-licensed doctor reviews and countersigns hormonal and peptide recommendations. Compliant and trustworthy.
  • Closed loop with HealthHub Research — advisors recommend from our own premium peptide catalogue. Consult → order stays in-house.
Revenue Streams
Initial Consult 60 min · physician + advisor €350
Follow-Up 30 min · protocol adjustment €180
Quick Check-In 15 min · single query €90
Peptide Orders HealthHub Research catalogue 40–60%
Advisor Commission Platform fee per session 20–30%
Unit Economics
First-year LTV per client
€900–1,400
Estimated CAC (organic)
€40–80
LTV : CAC ratio
15–20x
Gross margin (consultations)
~72%
Target MRR at 100 clients/mo
€35K
Target ARR at 1,200 clients/yr
€420K
Roadmap
NOW
MVP LiveClinic + Research sites, EU physician, automated booking, Stripe payments, first paid clients
Q3 2026
Advisor Marketplace10 vetted advisors across longevity, hormones, nutrition, performance. EU rollout begins
Q4 2026
Platform & AppClient portal, advisor dashboard, protocol tracking, lab integrations, subscription tier
2027
Series A100+ advisors, 5 EU markets, corporate wellness channel
Traction — Zero Marketing Spend
MVP live — clinic.healthhub.one + research.healthhub.one fully operational
EU physician onboarded — Greece-based MD, online consultations running
38+ compound catalogue — 99.2% purity, UK lab, live orders
Fully automated — Cal.com booking, Stripe payments, Netlify Forms CRM
Comparable Raises
Syneron Bio
Peptide drug platform · Series B · Apr 2026
$150M raised
MAKE Wellness
Bioactive peptide wellness · $100M Year 1
$100M+ revenue
Zoe Health
Personalised nutrition · UK
$53M raised
Function Health
Biomarker-led wellness · US
$52M raised
MK2 Biotechnologies
Peptide platform · Munich · EU
EU funded
HealthHub
EU longevity advisory — our position
Seed open · €2M
Use of Funds · €2M
Platform & Tech Development
35% · €700K
Marketing & Client Acquisition
25% · €500K
Advisor Acquisition & Vetting
20% · €400K
Legal, Compliance & GDPR
10% · €200K
Operations & Working Capital
10% · €200K
Why Now
  • No EU competitor doing longevity + peptides + vetted advisors at scale — the white space is wide open right now.
  • Regulatory window — wellness coaching largely unregulated across the EU. First mover establishes the standard.
  • Peptide investment is exploding — Syneron Bio raised $150M Series B in April 2026. MAKE Wellness hit $100M revenue in year one. Investor appetite is at an all-time high.
  • MVP already built — not a concept deck. Live product, paying clients, proven demand.
  • HERMOÉ — Functional drink range
    wellness HERMOÉ CYCLE
    PMS · Balance
    Calm · Energy
    250ml

    Cycle

    PMS support

    wellness HERMOÉ BALANCE
    Perimenopause
    Calm · Restore
    250ml

    Balance

    Perimenopause

    wellness HERMOÉ RESTORE
    Andropause
    Energy · Drive
    250ml

    Restore

    Coming soon

    FMCG functional drink targeting EU retail — supermarkets, pharmacies, petrol stations, gym chains. No direct EU competitor. Trademark application pending.

    One integrated ecosystem
    HealthHub ecosystem Hub and spoke: HealthHub Group connects to Research, Clinic, Advisors, Hormonal Hubs, and HERMOÉ HealthHub Group Research Peptide supply Clinic Consultations Hormonal Hubs Walk-in advisory HERMOÉ Functional drink Advisors EU marketplace Each spoke feeds the others — one flywheel, five revenue streams